Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
20 December 2024Fighting Antimicrobial Resistance in Developing Countries: Innovative Approaches and Challenges
Antimicrobial resistance (AMR) is a global health concern, particularly impacting developing countries. A collection of eight studies explores the pressing need for integrated, multidisciplinary strategies to address AMR effectively. Key Findings Surveillance and Monitoring The studies stress the importance of robust surveillance systems to track AMR trends. Molecular diagnostics and epidemiological analyses are crucial for […]
Read more... -
19 December 2024A Screen of Traditional Chinese Medicinal Plant Extracts Reveals 17 Species with Antimicrobial Properties
Antimicrobial resistance (AMR) is a growing threat to global healthcare, with ESKAPEE pathogens becoming resistant to antibiotics. Traditional Chinese Medicine (TCM) has been used for centuries to treat various ailments, but no plant-derived antibacterial drugs are currently approved for clinical use. This study evaluates the antimicrobial properties of extracts from TCM plants, finding 17 plant […]
Read more... -
16 December 2024Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics
A study using chemical genetics data from the Escherichia coli single-gene deletion library in 40 antibiotics found that bacteria can develop resistance to one antibiotic, leading to cross-resistance and collateral sensitivity. The study expanded the number of known interactions by threefold and validated 64/70 inferred interactions using experimental evolution. The study also applied collateral-sensitive drug […]
Read more...
More news related to Smart innovation